-transparent.png){kind=logo}
To evaluate the potential of interferon-alpha 2b (IFN-alpha) as an antifibrotic treatment after glaucoma filtering surgery, we studied its ability to inhibit mitogen-induced proliferation of human Tenon's capsule fibroblasts in vitro, as shown by [3H]-thymidine incorporation. IFN-alpha inhibited fetal calf serum-induced proliferation in a dose-dependent manner in concentrations ranging from 10 to 10,000 IU/ml (P < 0.001). Inhibition was also found when IFN-alpha was added prior to the mitogen (P = 0.001); this inhibitory effect lasted at least 3 days. We suggest that IFN-alpha deserves further evaluation as a possible agent for the control of ocular fibrosis.
Related Publications
M Gillies, and
T Su, and
M Sarossy, and
F Hollows
December 1998,
Yan ke xue bao = Eye science,
M Gillies, and
T Su, and
M Sarossy, and
F Hollows
January 1996,
Ophthalmic research,
M Gillies, and
T Su, and
M Sarossy, and
F Hollows
October 1991,
Investigative ophthalmology & visual science,
M Gillies, and
T Su, and
M Sarossy, and
F Hollows
November 1992,
Investigative ophthalmology & visual science,
M Gillies, and
T Su, and
M Sarossy, and
F Hollows
September 1991,
Investigative ophthalmology & visual science,
M Gillies, and
T Su, and
M Sarossy, and
F Hollows
April 2005,
The British journal of ophthalmology,
M Gillies, and
T Su, and
M Sarossy, and
F Hollows
April 2000,
Current eye research,
M Gillies, and
T Su, and
M Sarossy, and
F Hollows
February 1999,
Current eye research,
M Gillies, and
T Su, and
M Sarossy, and
F Hollows
March 2004,
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
M Gillies, and
T Su, and
M Sarossy, and
F Hollows
September 2000,
Yan ke xue bao = Eye science,
